NCT07065773View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
Onychomycosis of Toenail
Interventions
DRUG

Trichostatin A

Topical Study Drug

Trial Locations (5)

24551

RECRUITING

Vanda Investigational Site, Forest

55112

RECRUITING

Vanda Investigational Site, New Brighton

78660

RECRUITING

Vanda Investigational Site, Pflugerville

80210

RECRUITING

Vanda Investigational Site, Denver

94538

RECRUITING

Vanda Investigational Site, Fremont

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY